Source comparison
BPC-157 for Sprained Ankle Research Comparison
BPC-157 (research peptide) Upregulates VEGF and FGF-2 to promote angiogenesis and collagen synthesis at injury sites Animal models only. No human trials 2–3 weeks in rat models (50% reduction vs controls) Promising biological mechanism with robust animal data
This comparison does not assign a generated winner or score.
- BPC-157 (research peptide)
- Upregulates VEGF and FGF-2 to promote angiogenesis and collagen synthesis at injury sites
- Animal models only. No human trials
- 2–3 weeks in rat models (50% reduction vs controls)
- Promising biological mechanism with robust animal data but zero clinical validation in humans. Currently unregulated
- Standard RICE protocol (Rest, Ice, Compression, Elevation)
- Reduces acute inflammation and edema through vasoconstriction and mechanical compression
- Decades of clinical use. Level C evidence
- 4–6 weeks for Grade II sprains
- Gold standard conservative treatment with minimal risk but slow recovery for high-grade injuries
- Platelet-Rich Plasma (PRP) injections
- Delivers concentrated growth factors (PDGF, TGF-beta) directly to ligament tear
- Mixed clinical evidence. Some RCTs show benefit, others show no difference vs saline
- 3–4 weeks with accelerated rehab
- FDA-approved autologous treatment with established safety profile but inconsistent efficacy across studies
- NSAIDs (ibuprofen, naproxen)
- Inhibits COX-2 to reduce prostaglandin synthesis and blunt inflammatory response
- Well-established but may delay healing if used beyond 72 hours post-injury
- Same as RICE. Symptom management only
- Effective for acute pain control but evidence suggests prolonged use impairs collagen synthesis during proliferative phase